The General Plan

Contract

CMS Finalizes Revised Conditions for Coverage for Organ Procurement Organizations, Effective January 2027

A final rule from CMS clarifies operational and administrative requirements for OPOs — including designation, re-certification, competition, and appeals — while preserving the performance accountability framework established in 2020.

What the Rule Does

The Centers for Medicare & Medicaid Services (CMS) has issued a final rule revising the Conditions for Coverage for Organ Procurement Organizations (OPOs) under 42 CFR 486. The rule revises definitions, updates designation requirements for OPOs, clarifies when an OPO's service area is open for competition, and updates the process for appeals. The rule also addresses Quality Assessment and Performance Improvement (QAPI) requirements and information management provisions, according to the document. These regulations are effective on January 4, 2027.

Background and Rationale

The document states that at any given time, at least 100,000 people are on the waiting list for a lifesaving transplant and that every 8 minutes, another person is added to the transplant waiting list. The document explains that OPOs perform essential functions — obtaining consent for donation, working with the Organ Procurement and Transplantation Network (OPTN) to match organs with recipients, procuring viable organs, and delivering organs in transplantable condition — and that optimal OPO performance is therefore a rate-limiting factor on the success of the entire organ transplant system.

The document traces the rule's origins to a 2019 Executive Order directing the Secretary of Health and Human Services to enhance organ procurement and utilization and to establish more transparent, reliable, and enforceable metrics for OPO performance. In response, CMS published a December 2020 final rule revising outcome measures to drive performance improvement. Since that 2020 rule, CMS states it received many inquiries from OPOs and others seeking clarification on operational and administrative elements, with inquiries increasing in frequency and volume as the system moved closer to the end of the 2022–2026 re-certification cycle. CMS published a proposed rule on January 30, 2026 (91 FR 4190) to address those questions, and the current document is the final rule resulting from that process.

Scope and Accountability Framework

The rule provides what the agency describes as additional operational flexibility for OPOs to achieve high performance, with the stated goal of increasing the successful procurement, distribution, and transplantation of life-saving organs. Critically, the document states that this final rule does not revise the focus on improving the volume of donors and transplants assessed in the outcome measures, nor does it revise the tier structure used for re-certification and de-certification of OPOs. The agency characterizes the rule as clarifying and refining operational and administrative requirements while maintaining the accountability framework established in the December 2020 OPO final rule.

The document also includes a severability clause, stating that if any provision of the rule is held invalid or unenforceable, the remaining provisions shall continue in effect to the maximum extent permitted by law.

What to Watch

The rule's effective date of January 4, 2027 is the key upcoming deadline. The document notes that provisions governing the competition process and re-certification are particularly relevant as the system approaches the conclusion of the 2022–2026 re-certification cycle.

What This Means for Recipients

State, local, and tribal governments and their consultants involved in health facilities oversight or transplant-related programs should note that OPO designation, service area competition, and appeals processes are all revised under this rule, effective January 4, 2027. The rule is classified as economically significant. The outcome measure standards and tier structure governing OPO re-certification and de-certification remain unchanged from the December 2020 final rule, meaning the performance accountability requirements affecting OPOs operating within or serving any jurisdiction are preserved as previously established.

Related

Sources

15 cited

Every hard fact above is grounded in and cited to a primary source record.

  1. The final rule revises the Conditions for Coverage for Organ Procurement Organizations (OPOs) under 42 CFR 486.

    federalregister.gov
  2. The rule revises definitions, updates designation requirements for OPOs, clarifies when an OPO's service area is open for competition, and updates the process for appeals.

    federalregister.gov
  3. These regulations are effective on January 4, 2027.

    federalregister.gov
  4. The document states that at any given time, at least 100,000 people are on the waiting list for a lifesaving transplant.

    federalregister.gov
  5. According to the document, every 8 minutes, another person is added to the transplant waiting list.

    federalregister.gov
  6. In 2019, President Trump issued Executive Order 13879 directing the Secretary to enhance organ procurement and utilization and to establish more transparent, reliable, and enforceable metrics for OPO performance.

    federalregister.gov
  7. CMS published a December 2020 final rule (85 FR 77898) revising outcome measures to drive performance improvement.

    federalregister.gov
  8. CMS states it received many inquiries from OPOs and others seeking clarification on operational and administrative elements, with inquiries increasing in frequency and volume as the system moved closer to the end of the 2022–2026 re-certification cycle.

    federalregister.gov
  9. CMS published a proposed rule on January 30, 2026 (91 FR 4190) to address operational and administrative questions.

    federalregister.gov
  10. The final rule does not revise the focus on improving the volume of donors and transplants assessed in the outcome measures, nor does it revise the tier structure used for re-certification and de-certification of OPOs.

    federalregister.gov
  11. The rule is classified as economically significant.

    federalregister.gov
  12. The rule includes a severability clause stating that if any provision is held invalid or unenforceable, remaining provisions shall continue in effect to the maximum extent permitted by law.

    federalregister.gov
  13. The rule addresses Quality Assessment and Performance Improvement (QAPI) requirements and information management provisions.

    federalregister.gov
  14. The rule spans 55 Federal Register pages.

    federalregister.gov
  15. The document explains that OPOs perform essential functions including obtaining consent for donation, working with the Organ Procurement and Transplantation Network (OPTN) to match organs with recipients, procuring viable organs, and delivering organs in transplantable condition.

    federalregister.gov